Skip to content
Wenlo
Sign in
← Markets

Roivant Sciences Ltd.

Roivant Sciences Ltd. (ROIV) — Form 144: Proposed sale of shares

144ROIVFiled Oct 28, 2026, 4:35 PM ET

AI-generated summary

Eric Venker, Officer of Roivant Sciences Ltd., proposed to sell 200,000 Common shares with an aggregate market value of $7,317,764. The sale will be executed through Rockefeller Financial LLC. The sales will be made pursuant to a Rule 10b5-1 trading plan adopted on 06/30/2026.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Seller
Venker Eric
Relationship
Officer
Shares to sell
200,000
Market value
$7,317,764.00
Approximate sale date
Oct 28, 2026
Broker
Rockefeller Financial LLC
Acquired (1)
Mar 20, 2025 · Options Exercise - Grant Date 04/20/2022
Acquired (2)
Feb 20, 2025 · RSU Grant 018305 - Grant date 05/20/2020
Acquired (3)
Jan 20, 2025 · RSU Grant 018305 - Grant date 05/20/2020
Acquired (4)
Mar 24, 2025 · RSU Grant 018305 - Grant date 05/20/2020
Acquired (5)
Mar 20, 2024 · RSU Grant 018861 - Grant date 05/20/2021
Acquired (6)
Nov 16, 2023 · RSU Grant 018861 - Grant date 05/20/2021
Acquired (7)
Oct 18, 2023 · RSU Grant 018861 - Grant date 05/20/2021
Acquired (8)
Jun 2, 2025 · Options Exercise - Grant Date 04/20/2022

Rule 10b5-1 plan · adopted Jun 30, 2026

Remarks
  1. The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/30/2026.

More ROIV filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.